Evidence map›Paper›PMID 33801901›Full record

ArticleNutrients2021

Effect of Trilobatin from

Hailiang Shen, Linhua Huang, Huating Dou, Yali Yang, Houjiu Wu

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Multidimensional Profiling of Chinese Sweet TeaFoods (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Nutrients · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Dietary supplementation withFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hailiang ShenCitrus Research Institute, Southwest University, Chongqing 400000, China.
Linhua HuangCitrus Research Institute, Southwest University, Chongqing 400000, China.
Huating DouCitrus Research Institute, Southwest University, Chongqing 400000, China.
Yali YangDepartment of Food Engineering and Nutritional Science, Shaanxi Normal University, Xi'an 710000, China.
Houjiu WuCitrus Research Institute, Southwest University, Chongqing 400000, China.
Citrus Research Institute · CNShaanxi Normal University · CNSouthwest University · CN

Funding

National Key Research and Development Program of China 2017YFD0400701-3National Natural Science Foundation of China 31701563the Key Research and Development Program of Shaanxi Province 2019NY-124the Research and Innovation Project of Graduate Students in Chongqing CYB19095
6 · The paper itself

Abstract

Trilobatin was identified as the primary bioactive component in the

Indexed as

Dietary SupplementsDiet, High-FatAnimalsAnti-Obesity AgentsBacillotaBacteroidetesBody WeightFagaceaeFatty Acids, VolatileFlavonoidsGastrointestinal MicrobiomeLiverMaleMetabolic Networks and PathwaysObesityOrgan SizeAnti-Obesity AgentsFatty Acids, VolatileFlavonoidsPolyphenolstrilobatinantiobesitygut microbiotaKEGG pathwayLithocarpus polystachyus Rehdtrilobatin

Identifiers

PMID33801901
PMCPMC8001797
OpenAlexW3135236138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.